794
Views
24
CrossRef citations to date
0
Altmetric
Author's View

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression

, , &
Article: e27402 | Received 28 Nov 2013, Accepted 02 Dec 2013, Published online: 01 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chunmei Fu, Tianle Ma, Li Zhou, Qing-Sheng Mi & Aimin Jiang. (2022) Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities. Immunological Investigations 51:8, pages 2133-2158.
Read now

Articles from other publishers (23)

Camille Niveau, Eleonora Sosa Cuevas, Benoît Roubinet, Mylène Pezet, Michel Thépaut, Stéphane Mouret, Julie Charles, Franck Fieschi, Ludovic Landemarre, Laurence Chaperot, Philippe Saas & Caroline Aspord. (2023) Melanoma tumour‐derived glycans hijack dendritic cell subsets through C ‐type lectin receptor binding . Immunology.
Crossref
Agnieszka Łazarczyk, Joanna Streb, Anna Glajcar, Anna Streb-Smoleń, Przemysław Hałubiec, Kacper Wcisło, Łukasz Laskowicz, Diana Hodorowicz-Zaniewska & Joanna Szpor. (2023) Dendritic Cell Subpopulations Are Associated with Prognostic Characteristics of Breast Cancer after Neoadjuvant Chemotherapy—An Observational Study. International Journal of Molecular Sciences 24:21, pages 15817.
Crossref
Eleonora Sosa Cuevas, Jenny Valladeau-Guilemond, Stephane Mouret, Benoît Roubinet, Florence de Fraipont, Ludovic Landemarre, Julie Charles, Nathalie Bendriss-Vermare, Laurence Chaperot & Caroline Aspord. (2022) Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients. Frontiers in Immunology 13.
Crossref
Wenping Lian, Zhongquan Wang, Yajie Ma, Yalin Tong, Xinyu Zhang, Huifang Jin, Shuai Zhao, Ruijing Yu, Shaotan Ju, Xinyun Zhang, Xiaona Guo, Tao Huang, Xianfei Ding & Mengle Peng. (2022) FABP6 Expression Correlates with Immune Infiltration and Immunogenicity in Colorectal Cancer Cells. Journal of Immunology Research 2022, pages 1-33.
Crossref
Jamila Kacher, Olivier Manches, Caroline Aspord, Hervé Sartelet & Laurence Chaperot. (2022) Impaired Antitumor Immune Response in MYCN -amplified Neuroblastoma Is Associated with Lack of CCL2 Secretion and Poor Dendritic Cell Recruitment . Cancer Research Communications 2:7, pages 577-589.
Crossref
Gang Wang, Jin-Qu Hu, Ji-Yuan Liu & Xiao-Mei Zhang. (2022) Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Chunmei Fu, Li Zhou, Qing-Sheng Mi & Aimin Jiang. (2022) Plasmacytoid Dendritic Cells and Cancer Immunotherapy. Cells 11:2, pages 222.
Crossref
Eleonora Sosa Cuevas, Nathalie Bendriss‐Vermare, Stephane Mouret, Florence De Fraipont, Julie Charles, Jenny Valladeau‐Guilemond, Laurence Chaperot & Caroline Aspord. (2022) Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80 + PDL1 − )‐pDC subset negatively correlated with clinical outcomes in melanoma patients . Clinical & Translational Immunology 11:5.
Crossref
Yi Yao, Chunmei Fu, Li Zhou, Qing-Sheng Mi & Aimin Jiang. (2021) DC-Derived Exosomes for Cancer Immunotherapy. Cancers 13:15, pages 3667.
Crossref
Ariel E. Marciscano & Niroshana Anandasabapathy. (2021) The role of dendritic cells in cancer and anti-tumor immunity. Seminars in Immunology 52, pages 101481.
Crossref
Marcin Domagala, Chloé Laplagne, Edouard Leveque, Camille Laurent, Jean-Jacques Fournié, Eric Espinosa & Mary Poupot. (2021) Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells. Cancers 13:2, pages 165.
Crossref
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil, Edwige Col, Florence De Fraipont, Nathalie Sturm, Julie Charles, Olivier Manches, Laurence Chaperot & Caroline Aspord. (2021) Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Clinical & Translational Immunology 10:11.
Crossref
Barbara Carreira, Rita C. Acúrcio, Ana I. Matos, Carina Peres, Sabina Pozzi, Daniella Vaskovich‐Koubi, Ron Kleiner, Mariana Bento, Ronit Satchi‐Fainaro & Helena F. Florindo. (2020) Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment. Advanced Therapeutics 4:1, pages 2000147.
Crossref
Chunmei Fu, Li Zhou, Qing-Sheng Mi & Aimin Jiang. (2020) DC-Based Vaccines for Cancer Immunotherapy. Vaccines 8:4, pages 706.
Crossref
Chunmei FuPeng Peng, Jakob LoschkoLi Feng, Phuong PhamWeiguo CuiKelvin P. LeeAnne B. Krug & Aimin Jiang. (2020) Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes. Proceedings of the National Academy of Sciences 117:38, pages 23730-23741.
Crossref
Pauline Girard, Benedicte Ponsard, Julie Charles, Laurence Chaperot & Caroline Aspord. (2020) Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints. Frontiers in Immunology 11.
Crossref
Eleonora Sosa Cuevas, Laurissa Ouaguia, Stephane Mouret, Julie Charles, Florence Fraipont, Olivier Manches, Jenny Valladeau‐Guilemond, Nathalie Bendriss‐Vermare, Laurence Chaperot & Caroline Aspord. (2020) BDCA1 + cDC2s, BDCA2 + pDCs and BDCA3 + cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients . Clinical & Translational Immunology 9:11.
Crossref
Lisa Haas & Anna C. Obenauf. (2019) Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment. Frontiers in Immunology 10.
Crossref
Taylor T. Chrisikos, Yifan Zhou, Natalie Slone, Rachel Babcock, Stephanie S. Watowich & Haiyan S. Li. (2019) Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer. Molecular Immunology 110, pages 24-39.
Crossref
Tessa Knox, Eva Sahakian, Debarati Banik, Melissa Hadley, Erica Palmer, Satish Noonepalle, Jennifer Kim, John Powers, Maria Gracia-Hernandez, Vasco Oliveira, Fengdong Cheng, Jie Chen, Cyril Barinka, Javier Pinilla-Ibarz, Norman H. Lee, Alan Kozikowski & Alejandro Villagra. (2019) Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Scientific Reports 9:1.
Crossref
Chunmei Fu & Aimin Jiang. (2018) Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment. Frontiers in Immunology 9.
Crossref
Dana Mitchell, Sreenivasulu Chintala & Mahua Dey. (2018) Plasmacytoid dendritic cell in immunity and cancer. Journal of Neuroimmunology 322, pages 63-73.
Crossref
Hassan Sadozai, Thomas Gruber, Robert Emil Hunger & Mirjam Schenk. (2017) Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma. Frontiers in Immunology 8.
Crossref